Abstract
Harmony Alliance Provides a Machine Learning Researching Tool to Predict the Risk of Relapse after First Remission in AML Patients Treated without Allogeneic Haematopoietic Stem Cell Transplantation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have